454 related articles for article (PubMed ID: 35980054)
21. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.
Qosa H; Miller DS; Pasinelli P; Trotti D
Brain Res; 2015 Dec; 1628(Pt B):298-316. PubMed ID: 26187753
[TBL] [Abstract][Full Text] [Related]
22. The impact of ATP-binding cassette transporters in the diseased brain: Context matters.
Baltira C; Aronica E; Elmquist WF; Langer O; Löscher W; Sarkaria JN; Wesseling P; de Gooijer MC; van Tellingen O
Cell Rep Med; 2024 Jun; 5(6):101609. PubMed ID: 38897176
[TBL] [Abstract][Full Text] [Related]
23. Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy.
Hartz AM; Bauer B
Mol Interv; 2010 Oct; 10(5):293-304. PubMed ID: 21045243
[TBL] [Abstract][Full Text] [Related]
24. Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.
Tournier N; Declèves X; Saubaméa B; Scherrmann JM; Cisternino S
Curr Pharm Des; 2011; 17(26):2829-42. PubMed ID: 21827411
[TBL] [Abstract][Full Text] [Related]
25. ABC Transporters Are Key Players in Alzheimer's Disease.
Pereira CD; Martins F; Wiltfang J; da Cruz E Silva OAB; Rebelo S
J Alzheimers Dis; 2018; 61(2):463-485. PubMed ID: 29171999
[TBL] [Abstract][Full Text] [Related]
26. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
[TBL] [Abstract][Full Text] [Related]
27. Evolutionary conservation of vertebrate blood-brain barrier chemoprotective mechanisms in Drosophila.
Mayer F; Mayer N; Chinn L; Pinsonneault RL; Kroetz D; Bainton RJ
J Neurosci; 2009 Mar; 29(11):3538-50. PubMed ID: 19295159
[TBL] [Abstract][Full Text] [Related]
28. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
[TBL] [Abstract][Full Text] [Related]
29. Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy.
Couyoupetrou M; Gantner ME; Di Ianni ME; Palestro PH; Enrique AV; Gavernet L; Ruiz ME; Pesce G; Bruno-Blanch LE; Talevi A
Mini Rev Med Chem; 2017; 17(3):205-215. PubMed ID: 27739362
[TBL] [Abstract][Full Text] [Related]
30. Effect of Neuroinflammation on ABC Transporters: Possible Contribution to Refractory Epilepsy.
Deng X; Xie Y; Chen Y
CNS Neurol Disord Drug Targets; 2018; 17(10):728-735. PubMed ID: 30152292
[TBL] [Abstract][Full Text] [Related]
31. ABC transporters and the blood-brain barrier.
Begley DJ
Curr Pharm Des; 2004; 10(12):1295-312. PubMed ID: 15134482
[TBL] [Abstract][Full Text] [Related]
32. ABC Transporters and Drug Resistance in Patients with Epilepsy.
Feldmann M; Koepp M
Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
[TBL] [Abstract][Full Text] [Related]
34. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
Zhang W
Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
[TBL] [Abstract][Full Text] [Related]
35. Intermittent Hypoxia and Its Impact on Nrf2/HIF-1α Expression and ABC Transporters: An in Vitro Human Blood-Brain Barrier Model Study.
Zolotoff C; Voirin AC; Puech C; Roche F; Perek N
Cell Physiol Biochem; 2020 Dec; 54(6):1231-1248. PubMed ID: 33326735
[TBL] [Abstract][Full Text] [Related]
36. Alterations in Expression and Function of ABC Family Transporters at Blood-Brain Barrier under Liver Failure and Their Clinical Significances.
Fan Y; Liu X
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30041501
[TBL] [Abstract][Full Text] [Related]
37. Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients.
Al-Majdoub ZM; Al Feteisi H; Achour B; Warwood S; Neuhoff S; Rostami-Hodjegan A; Barber J
Mol Pharm; 2019 Mar; 16(3):1220-1233. PubMed ID: 30735053
[TBL] [Abstract][Full Text] [Related]
38. ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.
Jablonski M; Miller DS; Pasinelli P; Trotti D
Brain Res; 2015 May; 1607():1-14. PubMed ID: 25175835
[TBL] [Abstract][Full Text] [Related]
39. The role of bacterial ATP-binding cassette (ABC) transporters in pathogenesis and virulence: Therapeutic and vaccine potential.
Akhtar AA; Turner DP
Microb Pathog; 2022 Oct; 171():105734. PubMed ID: 36007845
[TBL] [Abstract][Full Text] [Related]
40. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
Miller DS
Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
